Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
AZN
2 quarters
Position history for JPMorgan Chase & Co.'s holdings in AstraZeneca PLC
Yes. JPMorgan Chase holds 19,204,823 shares of AZN (AstraZeneca), worth $3.7B, as of its Q2 2026 13F filing. It increased the position by 613,901 shares (+3.3%) from Q1 2026. JPMorgan Chase has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.2% of JPMorgan Chase's reported 13F portfolio.
Current Value
$3.7B
Current Shares
19.2M
Total Value Change
+$62.8M
Total Shares Change
+613,901
Quarter-by-Quarter History
Other major holders of AZN: Vanguard Capital Management LLC, Capital International Investors, Norges Bank